Dr Amal Mattu breaks down the key updates — and lingering pitfalls — in the 2025 ACS guidelines that every acute care ...

I'm 64 and recently found out my new partner is HPV positive. I want to get tested but my GP is also my neighbour, and I'm ...

Through two ongoing research projects with the University of Malta, the non-governmental organisation Beating Hearts Malta (BHM) is looking to make huge strides for cancer patients' quality of life ...

Telemed Solutions, a cardiac device company, announced today the release of its initial product, the TM-12. The TM-12 is a PC-based wireless 12-Lead EKG system. It embeds a Bluetooth radio into an ECG ...

Credit: Natali _ Mis / Shutterstock. HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias.

Milestone results formed the basis of HeartBeam’s 12-lead ECG synthesis software application submitted to FDA in January 2025 SANTA CLARA, Calif.-- (BUSINESS WIRE)-- HeartBeam, Inc., (NASDAQ: BEAT), a ...

The study evaluated the mean difference in ECG intervals and amplitudes between HeartBeam’s synthesized 12-lead ECG and simultaneously collected standard 12-lead ECG that are important in ...

Data from the VALID-ECG study formed the basis of HeartBeam’s FDA application for the 12-lead ECG synthesis software. The company submitted for approval in January 2025.

EDA of Physionet Data set regarding "A Large Scale 12 Lead Electrocardiogram Database for Arrhythmia Study 1.0.0". This project focuses on the preprocessing of electrocardiogram (ECG) signals and ...

The Kardia 12L ECG. [Image courtesy of AliveCor] AliveCor announced today that it received FDA clearance for its Kardia 12L (12-lead) ECG (electrocardiogram) system. According to AliveCor, the ...

The 12-lead electrocardiogram device, called the Kardia 12L ECG System, is a hand-held version of the standard ECG device usually found in hospitals and used to diagnose heart conditions.